- Home
- ECVT vs ORIC Comparison
ECVT vs ORIC Comparison
Compare ECVT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECVT
- ORIC
- Stock Information
- Founded
- ECVT 1935
- ORIC 2014
- Country
- ECVT United States
- ORIC United States
- Employees
- ECVT N/A
- ORIC N/A
- Industry
- ECVT Major Chemicals
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- ECVT Industrials
- ORIC Health Care
- Exchange
- ECVT Nasdaq
- ORIC Nasdaq
- Market Cap
- ECVT 1.0B
- ORIC 940.8M
- IPO Year
- ECVT 2017
- ORIC 2020
- Fundamental
- Price
- ECVT $8.44
- ORIC $10.12
- Analyst Decision
- ECVT Strong Buy
- ORIC Strong Buy
- Analyst Count
- ECVT 4
- ORIC 9
- Target Price
- ECVT $10.00
- ORIC $18.29
- AVG Volume (30 Days)
- ECVT 1.6M
- ORIC 1.2M
- Earning Date
- ECVT 08-07-2025
- ORIC 08-11-2025
- Dividend Yield
- ECVT N/A
- ORIC N/A
- EPS Growth
- ECVT N/A
- ORIC N/A
- EPS
- ECVT N/A
- ORIC N/A
- Revenue
- ECVT $706,153,000.00
- ORIC N/A
- Revenue This Year
- ECVT $15.53
- ORIC N/A
- Revenue Next Year
- ECVT $5.11
- ORIC N/A
- P/E Ratio
- ECVT N/A
- ORIC N/A
- Revenue Growth
- ECVT 2.23
- ORIC N/A
- 52 Week Low
- ECVT $5.24
- ORIC $3.90
- 52 Week High
- ECVT $9.08
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- ECVT 46.97
- ORIC 43.96
- Support Level
- ECVT $8.64
- ORIC $10.00
- Resistance Level
- ECVT $9.07
- ORIC $11.62
- Average True Range (ATR)
- ECVT 0.24
- ORIC 0.63
- MACD
- ECVT -0.07
- ORIC -0.24
- Stochastic Oscillator
- ECVT 13.70
- ORIC 20.68
About ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.